Guides Collective
The Weekly Guide
Resources, research, and reflections — curated each week for the guides in our community.
JUN 19, 2026
From the Platform
What's new and coming to Guides Collective.
Revamping Guide dashboard to make it simpler and more intuitive. Updates in the next three weeks.
Further exploring what sucks about the video API we're using. Still exploring the best alternative.
Scheduling bugs are being assessed and solved.
Section 01
Industry Headlines
What's happening in the psychedelic space this week.
PSYPOST · JUNE 16, 2026
Brain Scans Reveal How Regular Psychedelic Users Process Emotional Threats
A brain imaging study found that regular psychedelic users identified angry facial expressions faster and with greater accuracy than non-users, showing more efficient emotional threat detection. The research revealed reduced neural reactivity to negative emotions but heightened activity for positive expressions — suggesting psychedelics may reshape how the brain processes emotional information over time.
PSYPOST · JUNE 14, 2026
A Single Dose of Psilocybin Provides Months of Relief From Chronic Suicidal Thoughts
A clinical trial found that a single 25mg dose of psilocybin with psychological support produced rapid, sustained reductions in chronic suicidal ideation — with 75% of treatment-resistant participants showing significant improvement by week three. Researchers say the results suggest psilocybin may rapidly and safely reduce chronic suicidal thoughts in severe depression cases that haven’t responded to conventional treatments.
PSYPOST · JUNE 12, 2026
Taking Psychedelics at Raves and Ceremonies May Help Heal Childhood Trauma
A longitudinal study found that adults with childhood trauma histories who used psychedelics at organized ceremonies or EDM events experienced substantial reductions in PTSD symptoms, complex PTSD, and internalized shame — along with enhanced feelings of connection. The intensity of the experience itself, including ego dissolution and emotional breakthroughs, directly predicted lasting psychological improvements observed two months later.
Section 02
From the Field
Perspectives and insights from leaders in the psychedelic space.
PSYPOST · JUNE 5, 2026
Magic Mushroom Compound Enhances the Effectiveness of a Common Nerve Pain Medication
Researchers found that psilocybin reduces nerve pain in mice for extended periods and significantly enhances the effectiveness of gabapentin, a standard pain medication. The compound appears to work by remodeling dysfunctional brain networks through serotonin receptor activation — potentially opening new options for chronic pain that resists conventional therapies.
PSYPOST · JUNE 4, 2026
Can MDMA Cure PTSD? A New Review of the Evidence Says It’s Too Early to Tell
A meta-analysis found MDMA-assisted therapy is linked to decreases in PTSD symptoms and improvements in everyday functioning — but researchers caution that larger, higher-quality trials with active controls and long-term follow-up are needed to verify its effectiveness. Evidence quality remains limited by the difficulty of properly blinding participants to who received the actual drug versus placebo.
Section 03
Personal Journeys
First-person accounts worth reading — perspectives that inform the work we do.
NORMALIZE PSYCHEDELICS
I Recovered from Opiate Addiction with DMT: Sam Fullerton's Story
Consuming up to 700mg of oxycodone daily, Sam Fullerton broke free from severe opioid dependence through DMT experiences during withdrawal — witnessing what he describes as his addiction physically leaving his body in a single session, permanently eliminating his cravings.
NORMALIZE PSYCHEDELICS
Unlocking Health with Mushrooms: Johnny's Transformation Story
LA real estate professional Johnny Haronian credits psilocybin mushrooms with motivating him to lose weight and transform his health — while also helping him overcome addiction, reconnect with his emotions, and strengthen his relationships in ways other approaches hadn't achieved.